The use of 99mTc(V)DMSA as imaging for the medullary thyroid carcinoma (MTC).
作者信息
Guerra U, Pizzocaro C, Terzi A, Giubbini R, Bestagno M
出版信息
J Nucl Med Allied Sci. 1988 Oct-Dec;32(4):242-7.
PMID:2852709
Abstract
摘要
相似文献
1
The use of 99mTc(V)DMSA as imaging for the medullary thyroid carcinoma (MTC).
J Nucl Med Allied Sci. 1988 Oct-Dec;32(4):242-7.
2
A new imaging agent for medullary carcinoma of the thyroid.
J Nucl Med. 1984 Mar;25(3):323-5.
3
Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid.
J Nucl Med. 1988 Oct;29(10):1746-7.
4
More on [99mTc](V)DMSA scintigraphy in patients with medullary carcinoma of the thyroid.
J Nucl Med. 1989 Aug;30(8):1420.
5
Tc-99m DMSA scintigraphy on patients with medullary thyroid carcinoma.
Radiobiol Radiother (Berl). 1987;28(5):642-4.
6
The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.
Br J Radiol. 1987 Nov;60(719):1089-92. doi: 10.1259/0007-1285-60-719-1089.
7
Clinical evaluation of 99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis.
Eur J Nucl Med. 1988;13(10):507-10. doi: 10.1007/BF00256625.
8
The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
Henry Ford Hosp Med J. 1989;37(3-4):175-7.
9
Positive scintigraphy of medullary thyroid cancer using 201Tl and alkalized 99mTc-DMSA.
Radiobiol Radiother (Berl). 1987;28(5):640-2.
10
Technetium-99m(V)-DMSA in the imaging of medullary thyroid carcinoma.
J Nucl Med. 1987 Feb;28(2):252-3.
引用本文的文献
1
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
Eur Radiol. 2009 Jun;19(6):1425-34. doi: 10.1007/s00330-008-1280-7. Epub 2009 Jan 21.
2
Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma.
J Endocrinol Invest. 1997 Oct;20(9):527-30. doi: 10.1007/BF03348014.
Zotero 插件